Using small molecule inhibitors of PDE10A and genetic ablation of PDE10A expression we show that PDE10A-mediated regulation of both branches of cyclic nucleotide signaling – cAMP and cGMP – has potent anti-neoplastic effects including decreased cell proliferation, cell cycle arrest, and increased apoptosis in ovarian cancer cells. The gene discussed is PDE10A; the disease is ovarian cancer.